(Q53328684)

13 May 2018

title

Abnormalities in Alzheimer's disease fibroblasts bearing the APP670/671 mutation. (English)

1 reference

13 May 2018

1 reference

Gibson GE

1

1 reference

13 May 2018

Vestling M

2

1 reference

13 May 2018

Zhang H

3

1 reference

13 May 2018

Szolosi S

4

1 reference

13 May 2018

Alkon D

5

1 reference

13 May 2018

Lannfelt L

6

1 reference

13 May 2018

Gandy S

7

1 reference

13 May 2018

Cowburn RF

8

1 reference

13 May 2018

publication date

1 November 1997

1 reference

13 May 2018

published in

Neurobiology of Aging

1 reference

13 May 2018

volume

18

1 reference

13 May 2018

issue

6

1 reference

13 May 2018

page(s)

573-580

1 reference

13 May 2018

A large Swedish family with Alzheimer's disease with a codon 670/671 amyloid precursor protein mutation. A clinical and genealogical investigation.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Inherent abnormalities in oxidative metabolism in Alzheimer's disease: interaction with vascular abnormalities.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Reduced protein kinase C activity in sporadic Alzheimer's disease fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Potassium channel dysfunction in fibroblasts identifies patients with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Soluble beta-amyloid induction of Alzheimer's phenotype for human fibroblast K+ channels

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Altered oxidation and signal transduction systems in fibroblasts from Alzheimer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Reduced Activities of Thiamine-Dependent Enzymes in the Brains and Peripheral Tissues of Patients With Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Calcium stores in cultured fibroblasts and their changes with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Cytosol protein kinase C downregulation in fibroblasts from Alzheimer's disease patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

The Swedish mutation causes early-onset Alzheimer's disease by beta-secretase cleavage within the secretory pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Role of Ca2+ in pyruvate dehydrogenase interconversion in brain mitochondria and synaptosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Calcium responses in human fibroblasts: a diagnostic molecular profile for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Increased inositol 1,4,5-trisphosphate accumulation correlates with an up-regulation of bradykinin receptors in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Increased beta-amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP670/671 mutation.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Alzheimer-type pathology in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Alzheimer and beta-amyloid-treated fibroblasts demonstrate a decrease in a memory-associated GTP-binding protein, Cp20

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Mitochondria from Alzheimer's fibroblasts show decreased uptake of calcium and increased sensitivity to free radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Amyloid precursor protein mutation causes Alzheimer's disease in a Swedish family

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Altered calcium uptake in cultured skin fibroblasts from patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Alteration of intracellular Fura-2 fluorescence by viscosity: a simple correction

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Decrease in calcium currents induced by aminoglycoside antibiotics in frog motor nerve endings

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Calcium ionophore increases amyloid beta peptide production by cultured cells

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Beta APP mRNA transcription is increased in cultured fibroblasts from the familial Alzheimer's disease-1 family.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Abnormality of the alpha-ketoglutarate dehydrogenase complex in fibroblasts from familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Reduced protein kinase C immunoreactivity and altered protein phosphorylation in Alzheimer's disease fibroblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Characterization of muscarinic acetylcholine receptors in cultured adult skin fibroblasts: effects of the Swedish Alzheimer's disease APP 670/671 mutation on binding levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

Differential regulation of adenylyl cyclase in fibroblasts from sporadic and familial Alzheimer's disease cases with PS1 and APP mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900149-8

7 January 2021

10.1016/S0197-4580(97)00149-8

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018